{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:21:57Z","timestamp":1793726517620,"version":"4.6.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008094","name":"College of Science and Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008094","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019687","name":"Hamad Bin Khalifa University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019779","name":"Qatar National Library","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.heliyon.2023.e14387","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T21:08:51Z","timestamp":1678482531000},"page":"e14387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Mitochondrial dysfunction: A notable contributor to the progression of Alzheimer's and Parkinson's disease"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0868-2440","authenticated-orcid":false,"given":"Abolaji Samson","family":"Olagunju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foysal","family":"Ahammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abiola Adeyanju","family":"Alagbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Titilayomi Ayomide","family":"Otenaike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0833-4828","authenticated-orcid":false,"given":"John Oluwafemi","family":"Teibo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahad Amer","family":"Alsaiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9291-9289","authenticated-orcid":false,"given":"Olabode","family":"Omotoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Enamul Kabir","family":"Talukder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e14387_bib1","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.24463","article-title":"Proteomic mapping of cytosol-facing outer mitochondrial and ER membranes in living human cells by proximity biotinylation","volume":"6","author":"Hung","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.heliyon.2023.e14387_bib2","doi-asserted-by":"crossref","first-page":"D1251","DOI":"10.1093\/nar\/gkv1003","article-title":"MitoCarta2.0: an updated inventory of mammalian mitochondrial proteins","volume":"44","author":"Calvo","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2023.e14387_bib3","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1093\/brain\/awx168","article-title":"Monitoring clinical progression with mitochondrial disease biomarkers","volume":"140","author":"Steele","year":"2017","journal-title":"Brain"},{"issue":"14","key":"10.1016\/j.heliyon.2023.e14387_bib4","article-title":"An insight into mitochondrial dysfunction and its implications in neurological diseases","volume":"22","author":"Rashid","year":"2021","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.heliyon.2023.e14387_bib5","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/hmg\/ddx129","article-title":"Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer's disease","volume":"26","author":"Reddy","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.heliyon.2023.e14387_bib6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/hmg\/ddx381","article-title":"Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer's disease","volume":"27","author":"Kandimalla","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.heliyon.2023.e14387_bib7","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/hmg\/ddw045","article-title":"Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease","volume":"25","author":"Yin","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.heliyon.2023.e14387_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/1871527317666180816100203","article-title":"Autophagy and mitochondria: targets in neurodegenerative disorders","volume":"17","author":"Kumar","year":"2018","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.heliyon.2023.e14387_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/hmg\/ddx381","article-title":"Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer's disease","volume":"27","author":"Kandimalla","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.heliyon.2023.e14387_bib10","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/cns.13140","article-title":"Mechanisms and roles of mitophagy in neurodegenerative diseases","volume":"25","author":"Wang","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.heliyon.2023.e14387_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mito.2019.07.003","article-title":"Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling","volume":"49","author":"Wu","year":"2019","journal-title":"Mitochondrion"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e14387_bib12","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jmb.2007.04.014","article-title":"A\u03b240 protects non-toxic A\u03b242 monomer from aggregation","volume":"369","author":"Yan","year":"2007","journal-title":"J. Mol. Biol."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e14387_bib13","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/brain\/awm318","article-title":"The role of autophagylysosome pathway in neurodegeneration associated with Parkinson's disease","volume":"131","author":"Pan","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.heliyon.2023.e14387_bib14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.biopha.2018.12.101","article-title":"Emerging pathways to neurodegeneration: dissecting the critical molecular mechanisms in Alzheimer's disease, Parkinson's disease","volume":"111","author":"Tan","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2023.e14387_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmed.2007.12.002","article-title":"Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease","volume":"14","author":"Reddy","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.heliyon.2023.e14387_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/487534","article-title":"Neurodegeneration in Friedreich's ataxia: from defective frataxin to oxidative stress","author":"Gomes","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.heliyon.2023.e14387_bib17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2217\/bmm.12.51","article-title":"Use of FDG PET as an imaging biomarker in clinical trials of Alzheimer's disease","volume":"6","author":"Herholz","year":"2012","journal-title":"Biomarkers Med."},{"key":"10.1016\/j.heliyon.2023.e14387_bib18","doi-asserted-by":"crossref","first-page":"18670","DOI":"10.1073\/pnas.1006586107","article-title":"Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model","volume":"107","author":"Du","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.heliyon.2023.e14387_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113441","article-title":"Transport and metabolic profiling studies of amentoflavone in caco-2 cells by uhplc-esi-ms\/ms and uhplc-esi-q-tof-ms\/ms","volume":"189","author":"Wang","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.heliyon.2023.e14387_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/175062","article-title":"Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease","author":"Hroudov\u00e1","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.heliyon.2023.e14387_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tins.2017.01.002","article-title":"Mitophagy and Alzheimer's disease: cellular and molecular mechanisms","volume":"40","author":"Kerr","year":"2017","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.heliyon.2023.e14387_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41531-018-0058-0","article-title":"Parkinson's foundation P4 group prevalence of Parkinson's disease across North America","volume":"4","author":"Marras","year":"2018","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.heliyon.2023.e14387_bib23","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13731","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"139","author":"Bose","year":"2016","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e14387_bib24","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ana.22034","article-title":"Apoptosis-inducing factor deficiency sensitizes dopaminergic neurons to Parkinsonian neurotoxins","volume":"68","author":"Perier","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.heliyon.2023.e14387_bib25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.tins.2014.03.004","article-title":"Parkin and PINK1: much more than mitophagy","volume":"37","author":"Scarffe","year":"2014","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.heliyon.2023.e14387_bib26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.brainres.2018.06.010","article-title":"LRRK2 and mitochondria: recent advances and current views","volume":"1702","author":"Singh","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.heliyon.2023.e14387_bib27","article-title":"Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: etiologies and therapeutic strategies","author":"Elfawy","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.heliyon.2023.e14387_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/biom10010059","article-title":"Neuroprotective effects of quercetin in alzheimer's disease","volume":"10","author":"Khan","year":"2020","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e14387_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/ph11030087","article-title":"Mitochondrial targeting in neurodegeneration: a heme perspective","volume":"11","author":"Fiorito","year":"2018","journal-title":"Pharmaceuticals"},{"issue":"17","key":"10.1016\/j.heliyon.2023.e14387_bib30","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.3390\/molecules26175327","article-title":"Therapeutic potential of natural products in treating neurodegenerative disorders and their future prospects and challenges","volume":"26","author":"Rahman","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2023.e14387_bib31","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00018-020-03670-0","article-title":"Mitochondrial microRNA (MitomiRs) in cancer and complex mitochondrial diseases: current status and future perspectives","volume":"78","author":"Purohit","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.heliyon.2023.e14387_bib32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","volume":"15","author":"Wang","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.heliyon.2023.e14387_bib41","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/hmg\/ddw045","article-title":"Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease","volume":"25","author":"Yin","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.heliyon.2023.e14387_bib42","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s12017-018-8499-5","article-title":"Cerebrospinal fluid C-reactive protein in Parkinson's disease: associations with motor and non-motor symptoms","volume":"20","author":"Sanjari Moghaddam","year":"2018","journal-title":"Neuromol Med"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e14387_bib43","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1038\/s41598-022-07909-7","article-title":"An assessment of the rescue action of resveratrol in parkin loss of function-induced oxidative stress in Drosophila melanogaster","volume":"12","author":"Adedara","year":"2022","journal-title":"Sci Rep."},{"issue":"14","key":"10.1016\/j.heliyon.2023.e14387_bib44","article-title":"An insight Into mitochondrial dysfunction and its implications in neurological diseases","volume":"22","author":"Waseem Rashid","year":"2021","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.heliyon.2023.e14387_bib45","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol. Neurodegen."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e14387_bib46","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/hmg\/ddx129","article-title":"Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer\u2019s disease","volume":"26","author":"Hemachandra Reddy","year":"2017","journal-title":"Hum. Mol. Genet."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023015943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023015943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T01:07:35Z","timestamp":1776215255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023015943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2405844023015943"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e14387","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial dysfunction: A notable contributor to the progression of Alzheimer's and Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e14387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e14387"}}